Search

The forest-based wellness industry, as a rapidly growing sector that integrates various business forms with extensive coverage and an extended industrial chain, is undergoing rapid development due to the increasing aging population and people’s suboptimal health conditions. As a forerunner in developing the forest-based wellness industry, Sichuan province is known for its early development, proactive efforts, diverse models, and significant impact in this industry. It has achieved certain milestones in terms of top-level design, pilot demonstration, standardized guidance, and public awareness campaigns to promote the development of this industry. Therefore, this paper utilizes Sichuan as a case study to systematically summarize and analyze the key practices made by the province in promoting the rapid development of the industry by investigating the development trajectory of the forest-based wellness industry. Additionally, it examines the development trends of this industry from the perspectives of supply, demand, and consumption. Finally, this paper proposes several measures to facilitate the high-quality development of the forest-based wellness industry. These measures encompass nurturing specialized talent in forest-based wellness, enhancing market players’ capabilities in this domain, conducting extensive research on technologies that promote this industry, actively seeking support from relevant policies, and promoting integrated development across diverse sectors. [ABSTRACT FROM AUTHOR]

Promoting ecological protection and high-quality development of the Yellow River Basin is a major national strategy that is planned and promoted by President Xi Jinping. As an important ecological formation in the Yellow River Basin and an important part of the “China Water Tower,” the Sichuan part of the Yellow River Basin plays an important role in ecological management of the whole basin. Therefore, based on the present situation and the rich experience of ecological protection and highquality development in the Yellow River Basin in Sichuan, this study puts forward a feasible plan for long-term ecological management of the Yellow River Basin in Sichuan

1. Ginkgolide B (GB), the most active of the ginkgolides, has been developed as a new drug for the treatment of vascular insufficiency; however, the pharmacokinetics of GB remain unclear. Here, we investigated the pharmacokinetics and urine excretion properties of GB in healthy Chinese subjects administered single- and multiple-dose injectable GB based on a new LC-MS/MS method. 2. GB pharmacokinetics were found to be dose-dependent from 20 to 60 mg. GB reached a steady state by day 6 with once-daily dosing at 40 mg. Systemic exposure to GB, as characterised by AUC0–∞, indicated accumulation following repeated once-daily dosing for seven consecutive days. The mean urinary cumulative excretion rate of GB in response to 20, 40, and 60 mg GB was 41.9 ± 18.5%, 32.9 ± 12.2%, and 43.9 ± 8.5%, respectively. 3. Dose-proportional pharmacokinetics of GB were observed after intravenous administration in healthy subjects. A gradual reduction in the volume of distribution and slight change in mean resistance time led us to conjecture the limited accumulation of GB based on distribution equilibrium in vivo. 4. This comprehensive study of the clinical pharmacokinetics of GB will provide useful information for its application and further development. [ABSTRACT FROM AUTHOR]